Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome

doi:10.1084/jem.170.1.343

This Article

	Full Text (PDF, 442K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Owen, W. F.
	Articles by Austen, K. F.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Owen, W. F.
	Articles by Austen, K. F.


Social Bookmarking

	What's this?

ARTICLES

Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome

WF Owen, ME Rothenberg, J Petersen, PF Weller, D Silberstein, AL Sheffer, RL Stevens, RJ Soberman and KF Austen
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.

We report that the hypodense eosinophil population in three patients with corticosteroid-unresponsive IHES was uniquely long lived ex vivo in the absence of exogenous cytokines. Serum or plasma from these patients conferred prolonged viability ex vivo to normodense eosinophils from reference donors and converted them to a functionally activated hypodense phenotype. In that antibody against IL-5 neutralized this activity in IHES serum, excessive quantities of this cytokine may account for the characteristic eosinophilia and long- lived, functionally augmented eosinophil phenotype in this disorder.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Park, Y.-J., Oh, E.-J., Park, J.-W., Kim, M., Han, K. (2006). Plasma Eosinophil Cationic Protein, Interleukin-5, and ECP/Eo Count Ratio in Patients with Various Eosinophilic Diseases. Annals of Clinical & Laboratory Science 36: 262-266 [Abstract] [Full Text]
Goddard, D. S., Yamanaka, K.-i., Kupper, T. S., Jones, D. A. (2005). Activation of Neutrophils in Cutaneous T-Cell Lymphoma. Clin. Cancer Res. 11: 8243-8249 [Abstract] [Full Text]
Klion, A. D., Law, M. A., Riemenschneider, W., McMaster, M. L., Brown, M. R., Horne, M., Karp, B., Robinson, M., Sachdev, V., Tucker, E., Turner, M., Nutman, T. B. (2004). Familial eosinophilia: a benign disorder?. Blood 103: 4050-4055 [Abstract] [Full Text]
Ochi, H., De Jesus, N. H., Hsieh, F. H., Austen, K. F., Boyce, J. A. (2000). IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc. Natl. Acad. Sci. USA 10.1073/pnas.180318697v1 [Abstract] [Full Text]
Means-Markwell, M., Burgess, T., deKeratry, D., O'Neil, K., Mascola, J., Fleisher, T., Lucey, D. (2000). Eosinophilia with Aberrant T Cells and Elevated Serum Levels of Interleukin-2 and Interleukin-15. NEJM 342: 1568-1571 [Full Text]
Karras, J. G., McGraw, K., McKay, R. A., Cooper, S. R., Lerner, D., Lu, T., Walker, C., Dean, N. M., Monia, B. P. (2000). Inhibition of Antigen-Induced Eosinophilia and Late Phase Airway Hyperresponsiveness by an IL-5 Antisense Oligonucleotide in Mouse Models of Asthma. J. Immunol. 164: 5409-5415 [Abstract] [Full Text]
Zia-Amirhosseini, P., Minthorn, E., Benincosa, L. J., Hart, T. K., Hottenstein, C. S., Tobia, L. A. P., Davis, C. B. (1999). Pharmacokinetics and Pharmacodynamics of SB-240563, a Humanized Monoclonal Antibody Directed to Human Interleukin-5, in Monkeys. J. Pharmacol. Exp. Ther. 291: 1060-1067 [Abstract] [Full Text]
Jaffar, Z., Roberts, K., Pandit, A., Linsley, P., Djukanovic, R., Holgate, S. (1999). B7 Costimulation Is Required for IL-5 and IL-13 Secretion by Bronchial Biopsy Tissue of Atopic Asthmatic Subjects in Response to Allergen Stimulation. Am. J. Respir. Cell Mol. Bio. 20: 153-162 [Abstract] [Full Text]
Adachi, T., Alam, R. (1998). The mechanism of IL-5 signal transduction. Am. J. Physiol. Cell Physiol. 275: C623-C633 [Abstract] [Full Text]
Trueb, R. M., Lubbe, J., Torricelli, R., Panizzon, R. G., Wuthrich, B., Burg, G. (1997). Eosinophilic Myositis With Eosinophilic Cellulitislike Skin Lesions: Association With Increased Serum Levels of Eosinophil Cationic Protein and Interleukin-5. Arch Dermatol 133: 203-206 [Abstract]
Penrose, J. F., Spector, J., Baldasaro, M., Xu, K., Boyce, J., Arm, J. P., Austen, K. F., Lam, B. K. (1996). Molecular Cloning of the Gene for Human Leukotriene C(4) Synthase. J. Biol. Chem. 271: 11356-11361 [Abstract] [Full Text]
Sun, Z., Yergeau, D. A., Tuypens, T., Tavernier, J., Paul, C. C., Baumann, M. A., Tenen, D. G., Ackerman, S. J. (1995). Identification and Characterization of a Functional Promoter Region in the Human Eosinophil IL-5 Receptor alpha Subunit Gene. J. Biol. Chem. 270: 1462-1471 [Abstract] [Full Text]
Cogan, E., Schandene, L., Crusiaux, A., Cochaux, P., Velu, T., Goldman, M. (1994). Clonal Proliferation of Type 2 Helper T Cells in a Man with the Hypereosinophilic Syndrome. NEJM 330: 535-538 [Full Text]
Varga, J., Uitto, J., Jimenez, S. A. (1992). The Cause and Pathogenesis of the Eosinophilia-Myalgia Syndrome. ANN INTERN MED 116: 140-147 [Abstract]
Zielinski, R. M., Lawrence, W. D. (1990). Interferon-{alpha} for the Hypereosinophilic Syndrome. ANN INTERN MED 113: 716-718 [Abstract]
Ochi, H., De Jesus, N. H., Hsieh, F. H., Austen, K. F., Boyce, J. A. (2000). IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc. Natl. Acad. Sci. USA 97: 10509-10513 [Abstract] [Full Text]